L-glutamic acid γ-monohydroxamate -: A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo

被引:43
作者
Goldwaser, I
Li, JP
Gershonov, E
Armoni, M
Karnieli, E
Fridkin, M
Shechter, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[4] Technion Israel Inst Technol, Inst Endocrinol, Rambam Med Ctr, IL-31096 Haifa, Israel
关键词
D O I
10.1074/jbc.274.37.26617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report that the vanadium ligand L-Glu(gamma)HXM potentiates the capacity of free vanadium ions to activate glucose uptake and glucose metabolism in rat adipocytes in vitro (by 4-5-fold) and to lower blood glucose levels in hyperglycemic rats in vivo (by 5-7-fold). A molar ratio of two L-Glu(gamma)HXM molecules to one vanadium ion was most effective. Unlike other vanadium ligands that potentiate the insulinomimetic actions of vanadium, L-Glu(gamma)HXM partially activated lipogenesis in rat adipocytes in the absence of exogenous vanadium, This effect was not manifested by D-Glu(gamma)HMM, At 10-20 mu M L-Glu(gamma)HXM, lipogenesis was activated 9-21%, This effect was approximately g-fold higher (140 +/- 15% of maximal insulin response) in adipocytes derived from rats that had been treated with vanadium for several days. Titration of vanadium(lV) with L-Glu(gamma)HXM led to a rapid decrease in the absorbance of vanadium(IV) at 765 nm, and V-51 NMR spectroscopy revealed that the chemical shift of vanadium(IV) at -490 ppm disappeared with the appearance of a signal characteristic to vanadium(V) (-530 ppm) upon adding one equivalent of L-Glu(gamma)HXM. In summary, L-Glu(gamma)HXM is highly active in potentiating vanadium-activated glucose metabolism in vitro and in vivo and facilitating glucose metabolism in rat adipocytes in the absence of exogenous vanadium probably through conversion of trace intracellular vanadium into an active insulinomimetic compound. We propose that the active species is either a 1:1 or 2:1 L-Glu(gamma)HXM vanadium complex in which the endogenous vanadium(IV) has been altered to vanadium(V), Finally we demonstrate that L-Glu(gamma)HXM- and L-Glu(gamma)HXM vanadium-evoked lipogenesis is arrested by wortmannin and that activation of glucose uptake in rat adipocytes is because of enhanced translocation of GLUT4 from low density microsomes to the plasma membrane.
引用
收藏
页码:26617 / 26624
页数:8
相关论文
共 51 条
[1]   MODULATION OF THE ACTIVITY OF GLUCOSE TRANSPORTERS (GLUT) IN THE AGED OBESE RAT ADIPOCYTE - SUPPRESSED FUNCTION, BUT ENHANCED INTRINSIC ACTIVITY OF GLUT [J].
ARMONI, M ;
HAREL, C ;
BURVIN, R ;
KARNIELI, E .
ENDOCRINOLOGY, 1995, 136 (08) :3292-3298
[2]   Glutamic acid gamma-monohydroxamate and hydroxylamine are alternate substrates for Escherichia coli asparagine synthetase B [J].
Boehlein, SK ;
Schuster, SM ;
Richards, NGJ .
BIOCHEMISTRY, 1996, 35 (09) :3031-3037
[3]   LONG-TERM IMPROVEMENT OF GLUCOSE-HOMEOSTASIS BY VANADATE IN OBESE HYPERINSULINEMIC FA/FA RATS [J].
BRICHARD, SM ;
POTTIER, AM ;
HENQUIN, JC .
ENDOCRINOLOGY, 1989, 125 (05) :2510-2516
[4]   VANADATE TREATMENT MARKEDLY INCREASES GLUCOSE-UTILIZATION IN MUSCLE OF INSULIN-RESISTANT FA/FA RATS WITHOUT MODIFYING GLUCOSE TRANSPORTER EXPRESSION [J].
BRICHARD, SM ;
ASSIMACOPOULOSJEANNET, F ;
JEANRENAUD, B .
ENDOCRINOLOGY, 1992, 131 (01) :311-317
[5]   LONG-TERM IMPROVEMENT OF GLUCOSE-HOMEOSTASIS BY VANADATE TREATMENT IN DIABETIC RATS [J].
BRICHARD, SM ;
OKITOLONDA, W ;
HENQUIN, JC .
ENDOCRINOLOGY, 1988, 123 (04) :2048-2053
[6]   THE ROLE OF VANADIUM IN THE MANAGEMENT OF DIABETES [J].
BRICHARD, SM ;
HENQUIN, JC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (08) :265-270
[7]   MARKED IMPROVEMENT OF GLUCOSE-HOMEOSTASIS IN DIABETIC OB OB MICE GIVEN ORAL VANADATE [J].
BRICHARD, SM ;
BAILEY, CJ ;
HENQUIN, JC .
DIABETES, 1990, 39 (11) :1326-1332
[8]  
CASTEEN ND, 1981, BIOL MAGN RESON, V2, P53
[9]   ORAL VANADYL SULFATE IMPROVES HEPATIC AND PERIPHERAL INSULIN SENSITIVITY IN PATIENTS WITH NON-LNSULIN-DEPENDENT DIABETES-MELLITUS [J].
COHEN, N ;
HALBERSTAM, M ;
SHLIMOVICH, P ;
CHANG, CJ ;
SHAMOON, H ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2501-2509
[10]  
Crans D.C., 1994, COMMENT INORG CHEM, V16, P1, DOI 10.1080/02603599408035850